The 114th edition of the Research Digest covers studies on potential treatments, biomarkers, and risk factors for long COVID and ME/CFS. Highlights include intravenous immunoglobulin as a possible therapy, biomarkers distinguishing long COVID patients with ME/CFS symptoms, a large paediatric study on risk factors and recovery, and a review of microRNAs in disease mechanisms. We
Welcome to the 113th and final edition of the Research Digest for 2024. This edition highlights significant findings on the growing challenges of long COVID and its connection to ME/CFS. The featured articles delve into the global, social, and economic impacts of long COVID, explore opportunities for research and treatment, and underscore the urgent need
Welcome to the 112th edition of Emerge Australia’s Research Digest. This month, we look at the latest research on ME/CFS and post-COVID conditions. The studies explore how common these conditions are, the symptoms they share, and how they affect the body, including metabolism and heart health. They also look at the possibility of personalised treatments.
Welcome to the 111th edition of Emerge Australia’s Research Digest. This month, we highlight studies that explore how individuals with ME/CFS adapt their technology use and investigate how physical activity-induced post-exertional malaise (PEM) reveals insights into microvascular changes and immunometabolic interactions in those living with ME/CFS and post-COVID. We also feature the largest two-day cardiopulmonary
Welcome to Edition #110 of Emerge Australia’s Research Digest. This month’s edition offers insights into long-term observations and potential biomarkers for long COVID, alongside an in-depth review of ME/CFS—ideal for those new to ME/CFS—covering its challenging diagnosis and the need for enhanced research and treatment strategies. Contributing Digesters: Ryan, Shan, Solène and Jyothsna. You can
Welcome to the 109th edition of Emerge Australia’s Research Digest. This month, we summarise articles that delve into a deeper understanding of the pathophysiological of long COVID and its connection to ME/CFS, along with a report on the burden of long COVID in Western Australia. Contributing Digesters: Jyothsna, Solène, Sarah, and Shan. You can also
Welcome to the 108th edition of Emerge Australia’s Research Digest, where we explore the latest research and media releases that are shaping our understanding of ME/CFS and long COVID. In this edition, we feature a study evaluating the application of an objective marker of ME/CFS to those with post-COVID syndrome. We also highlight recent reviews
Welcome to the 107th edition of Emerge Australia’s Research Digest, where we delve into recent research and media releases shaping our understanding of ME/CFS and long COVID. In this issue, we focus on pivotal studies and insightful reports that shed light on the blood-brain disruption in those with long COVID, and MRI studies that show
Welcome to the 106th edition of Emerge Australia’s Digest. In this month’s issue, we explore literature that delves deeper into the connections between metabolic and immune alterations in long COVID and ME/CFS. We also highlight reports on the long-term effects of SARS-CoV-2 in children and a detailed analysis of the clinical phenotypes identified in a
Welcome to the 105th edition of Emerge Australia’s Digest. In this month’s issue, we delve into a single-cell RNA sequencing project aimed at understanding the impact of exercise on PEM in individuals living with ME/CFS. Furthermore, we feature a review highlighting the parallels between ME/CFS and long COVID, along with a media report emphasising the
Greetings and welcome to the 104th edition of Emerge Australia’s Research Digest. In this edition, besides showcasing the latest research in the realms of ME/CFS and long COVID, we are experimenting with the integration of ‘text-to-speech’ technology. This enhancement allows subscribers not only to read the summaries, but also to listen to them. Just click
Welcome to the 103rd edition of Emerge Australia’s Research Digest. The first edition of the year features studies that illuminate various aspects of research related to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-acute COVID-19 syndrome, as well as insights and experiences from those living with ME/CFS regarding healthcare services. Contributing Digesters: Sarah, Solène, Shan and
Welcome to the 102nd edition of the Research Digest. This year’s final edition delves into research identifying potential biomarkers for long COVID and those meeting ME/CFS consensus criteria. We also highlight an Australian study assisted by Emerge Australia, showcasing the significant contribution of the ME/CFS patient/carer advisory group in determining the economic burden of ME/CFS
Welcome to the 101st edition of the Research Digest. This month’s edition features articles that explore exercise pathophysiology through invasive cardiopulmonary exercise testing, the role of orthostatic hemodynamic changes in cognitive impairment in long COVID and ME/CFS, and clinical guidance for the diagnosis and management of ME/CFS. You can also join our community and choose to
Welcome to the 100th edition of Emerge Australia’s Research Digest! To commemorate the milestone of our 100th issue, we’re shining a light on Emerge Australia’s own contribution to ME/CFS (and now long COVID) research, with the launch of AusME, the new Australian ME/CFS and long COVID Registry and Biobank. This months Contributor and Digest Editor:
In this 99th edition of the Research Digest, we highlight the discovery of WASF3, a key protein linked to exercise intolerance in ME/CFS. We also explore the use of health survey tools to better convey the burden of ME/CFS in Australia. Additionally, we delve into the analysis of plasma samples, identifying promising metabolites for diagnosing
Welcome to the 98th edition of the Research Digest. This edition features articles that contribute to our understanding of ME/CFS and long COVID. Alongside a Swiss report detailing the experiences of individuals with ME/CFS, the digest presents research on the enduring cognitive effects of COVID-19 and a study demonstrating the advantages of adhering to pacing
Welcome to the 97th edition of the Research Digest. July’s edition features ME/CFS studies that assess the potential diagnostic markers for ME/CFS and an article suggesting the immune and metabolic responses to intestinal cell damage are suppressed, in those living with ME/CFS. July’s edition also highlights Emerge Australia’s CEO Anne Wilson, and her focus on empowering change, for invisible illnesses.
Welcome to the 96th edition of the Research Digest. This month’s edition presents study outcomes demonstrating the presence of POTS in ME/CFS and further evidence that implicates the dysregulation of cytokine signalling in ME/CFS. This month’s Research Digest also highlights Emerge Australia’s efforts alongside members of the ME/CFS community and key stakeholders, to launch the Parliamentary Friends Group for ME/CFS, a meeting that took place at Parliament House on June 13th, 2023.
Welcome to the 95th edition of the Research Digest. This edition features a study looking at transcriptomic changes in those with ME/CFS following an exercise challenge and examines ME/CFS symptom differences in Black and White individuals. This edition also highlights the impact of long COVID in Australia and the Conversation hour discusses long COVID, in the context of how it’s changing the way we respond to ME/CFS.
Welcome to the 94th edition of the Research Digest. This month’s edition summarises research studies investigating the impact of exercise on post-exertional malaise, offering invaluable insights into exercise pathophysiology for both ME/CFS and long COVID. This month’s edition also highlights the long-awaited report from the parliamentary inquiry into long COVID, which includes a recommendation for more research and patient support for those living with ME/CFS.
Welcome to the 93rd edition of the Research Digest. This month’s edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about long COVID and finally, a local study sheds light on brain structure changes that are common to long COVID and ME/CFS.
Welcome to the 92nd edition of the Research Digest. This month recapitulates research studies that extend our understanding of ME/CFS and long COVID. The effect of exercise on the content of extracellular vesicles is investigated for ME/CFS and for long COVID symptoms. This edition also highlights comments made by Professor Brendan Crabb, CEO of the Burnet Institute encouraging the government to change the narrative to prevent the infection of COVID-19 and limit the impact of long COVID.
Welcome to the 91st edition of the Research Digest. In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid. The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilsons call for the government to better recognise those living with invisible disabilities.
Welcome to the 90th edition of the Research Digest. This month’s edition features ME/CFS studies investigating microclotting and antibody targeting of gut bacteria. Also presented, is the study of serum samples from post-covid syndrome and -/+ME/CFS patients, to further study endothelial dysfunction and the role of angiogenesis in both study groups. And finally, the recent ABC news article featuring Chris Armstrong and Anne Wilson is highlighted.
Welcome to the 89th edition of the Research Digest. This edition features a study looking more closely at blood cells to investigate mitochondrial abnormalities and immunological changes in ME/CFS. Furthermore, the effect of whole-body cryotherapy and activity monitoring in patients living with ME/CFS is presented. A link to Anne Wilson’s (Emerge Australias CEO) interview, responding to the lack of funding for ME/CFS and long COVID services in the federal budget is also highlighted.
Welcome to the 88th edition of the Research Digest. This edition features a study that aimed to determine the value of a simple, objective office-based test in the evaluation of OI and brain fog and large genetic association study that sought to identify chromosomal regions that may be linked to ME/CFS.
Welcome to the 87th edition of the Research Digest. This month’s edition highlights emerging evidence of endothelial dysfunction, to further demonstrate the striking similarities of Long Covid to ME/CFS. The metabolism of tryptophan and the role of its metabolites are also presented and postulated to influence symptoms of ME/CFS, as well as suggested mechanisms that may be responsible for the neuroinflammation observed in both ME/CFS and Long Covid.
Welcome to the 86th edition of the Research Digest. This edition reviews research articles looking further into infectious mononucleosis and its links with ME/CFS and the impact of ME/CFS, on the quality of life for patients and their partners. The digest also presents a recent ME/CFS brain imaging study that may prove useful diagnostically in the future and highlights the 2GB radio interview, featuring Emerge Australias CEO Anne Wilson, discussing the impact of changes to Telehealth.
Welcome to the 85th edition of Emerge Australias Research Digest. As a special edition, this months digest recapitulates Emerge Australias ME/CFS Awareness Week Research Panel webinar, providing insight into how our local ME/CFS community is contributing to ME/CFS research in Australia; via their contributions to the ME/CFS Biobank and You+ME Registry Australia.
Giving a voice to the unseen and unheard.
Sign up to our newsletter today.
Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR).
ABN/DGR: 22 385 438 041
Donations of $2 or more are tax-deductible.
1800 865 321 or
03 9529 1344
Level 7, 276 Flinders Street Melbourne VIC 3000
We acknowledge the Traditional Custodians of country and their connections to land, sea and community and pay our respect to Elders past and present, noting their continuing contributions, struggles, and achievements. We recognise that Aboriginal self-determination is a human right and honour the resilience and determination of many generations of Aboriginal people who have fought for this right to be upheld. This always was and always will be Aboriginal land. We understand sovereignty has never been ceded.
We welcome everyone. Our aim is for everyone to feel accepted, safe, affirmed and celebrated. We recognise diversity of culture, ethnicity, faith and spiritual beliefs, age, sexual orientation, gender identity/expression (LGBTIQ+), intersex status, socio-economic status, abilities, relationship status, and lived experience.
Emerge Australia Copyright © 2025 All Rights Reserved.
Design by Foundation Nova Diem
Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR).
ABN/DGR: 22 385 438 041
Donations of $2 or more are tax-deductible.
Level 7, 276 Flinders Street Melbourne VIC 3000
Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.
Emerge Australia Copyright © 2025 All Rights Reserved.
Design by Foundation Nova Diem